A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing.
My favorite part of this is your assumption that I have no personal experience in any of this. I know that it’s hard. I also know it’s possible to stop drinking and stop eating to excess. These are not analogies for me.